Find and Pitch Jounalists, Get Your Story Covered

Tags: metformin dementia opioid methadone tobacco

	Profile	Recent Articles on Subject
1	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	FDA Panel Rejects SGLT1/2 Inhibitor for Type 1 Diabetes - 11 days ago Weight-Loss Drug Overdoses; Record Number of Retracted Studies; Yoga and Cadavers - 11 months ago
2	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	STAT+: With new Wegovy data in hand, Novo Nordisk will file for approval in MASH - 11 days ago STAT+: Ozempic linked to lower risk of Alzheimer’s diagnosis in observational study - 19 days ago STAT+: Lilly’s Zepbound slashed risk of developing diabetes - 3 months ago STAT+: Positive trial results set up obesity drug Wegovy for use against heart failure - 7 months ago STAT+: Liver disease MASH is next target for obesity drugs in development - 9 months ago STAT+: What comes after Wegovy? The quest to eradicate obesity - 11 months ago Eli Lilly gets FDA approval to sell Mounjaro as obesity drug called Zepbound - about 1 year ago
3	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Some Disease Burden of Obesity Requires Pharmacotherapy, Not Just Lifestyle Interventions - 15 days ago FDA Grants Breakthrough Device Designation for System Maintaining Weight Loss After GLP-1 - 3 months ago Intermittent Fasting and Meal Replacements Improved Short-Term Glycemia - 4 months ago Tirzepatide Shows Improvements in MASH Without Worsening Fibrosis - 4 months ago INHALE-3 Study Data Shows Diabetes Care Is Not “One-Size-Fits-All” - 4 months ago Teva Launches Generic Formulation of Liraglutide in US - 5 months ago FLOW Trial Results Demonstrate Positive Kidney Outcomes With Semaglutide - 8 months ago Investigational GLP-1 Medication Found to Reduce Body Weight - 9 months ago Proposed Biosimilar Liraglutide Shows Non-Inferiority to Reference Drug for Type 2 Diabetes - 10 months ago Metformin Cessation Has Been Associated With Increased Dementia Incidence - about 1 year ago
4	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: We’re reading about a Merck drug-label controversy, Astellas pulling an application, and more - 15 days ago STAT+: Pharmalittle: We’re reading about Zepbound trial results, an Alnylam heart drug, and more - 3 months ago STAT+: Pharmalittle: We’re reading about Roche obesity drug data, fallout from the Menendez verdict, and more - 4 months ago STAT+: Pharmalittle: We’re reading about a Pfizer daily weight loss pill, a Novo Nordisk setback, and more - 4 months ago STAT+: Pharmalittle: We’re reading about Wegovy approved for heart risks, an ALS drug puzzle, and more - 8 months ago STAT+: Pharmalittle: We’re reading about Ozempic tackling kidney disease, OTC birth control, and more - 8 months ago STAT+: Pharmalittle: We’re reading about a U.S. vaccine panel, an abortion pill, and much more - 9 months ago STAT+: Pharmalittle: More U.S. states and cities are suing insulin makers; Biden looks to boost U.S. drug manufacturing amid shortages - 12 months ago STAT+: Pharmalittle: Lilly wins FDA approval for a weight-loss drug; AstraZeneca enters the race for an obesity pill - about 1 year ago STAT+: Pharmalittle: Sarepta Duchenne therapy misses primary endpoint; FDA holds panel for first CRISPR treatment for sickle cell - about 1 year ago STAT+: Pharmalittle: Novo halts Ozempic kidney failure trial after early signs of success; GSK settles California Zantac lawsuit - about 1 year ago
5	Rick Lange, MD, Texas Tech; Elizabeth Tracey MedPage Today Texas Tech University System, advancing higher education and health care. Lubbock, Texas higher educationhealth care	Metformin and Congenital Abnormalities; Deprescribing in Patients With Dementia - 17 days ago
6	Rachael Robertson MedPage Today Investigations & enterprise writer. Covers ob/gyn. @medpagetoday. NYC via PGH Investigative writinghealthcare	GLP-1 Drugs Tied to Reduced Risk of Uterine Fibroids - 19 days ago Metformin for Diabetes in Pregnancy: Maybe Not, Trial Says - 11 months ago
7	The Conversation Science Alert Science news. Official account. Australia science news	Type 2 Diabetes Drug Linked to 35% Lower Dementia Risk in Patients - 2 months ago
8	Kristen Monaco MedPage Today	Zepbound Can Prevent Diabetes; Menopause and Cognition; Tandem's Insulin Pump Update - 3 months ago Early-Stage GLP-1 Win in Obesity; An Argument for BMI's Value; Insulin Supply Issues - 4 months ago FDA Approves First-Ever Drug for Serious Liver Condition - 8 months ago More Mounjaro Doses Limited; At-Home Menopause Tests? Kimchi for Lower Obesity Risk - 9 months ago One Class of Antidiabetic Linked With Lower Kidney Stone Risk - 10 months ago Breast Cancer Drug Repurposed for Infant With Congenital Hyperinsulinism - 10 months ago In Acute Kidney Disease, SGLT2 inhibitors Were All-Around Protective - 10 months ago Phase II Wins, Losses for Obesity Drugs; More Positive Veozah Data; Walking Off T2D - 11 months ago Methotrexate Tied to Greater Risks for Older Patients With CKD - 12 months ago Mounjaro vs Ozempic for Obesity; New Microwave Ablation System; GAHT Erythrocytosis - 12 months ago Glucose Supplement Recalled; ADA Sued by Former Employee; Forteo Generic OK'd - 12 months ago Another Study Highlights Metformin's Dementia Protection Properties - about 1 year ago Hospitalizations With Fake Ozempic; Vosoritide OK'd for All Ages; Mounjaro for Kids? - about 1 year ago Farxiga Cuts A1c in Pediatric Diabetes; Late-Stage CAH Win; At-Home Menopause Test - about 1 year ago Smoking-Related Metabolic Changes Partly Drive Type 2 Diabetes Risk - about 1 year ago Faster-Acting Insulin Aspart Safe for Pregnant Women With Diabetes - about 1 year ago Diabetes in Night Owls; 'Paradigm-Shifting' Drugs; Transgender Trials Unethical? - about 1 year ago
9	Flora Graham Nature Writes Nature Briefing. Tweets own. On B’sky. London, United Kingdom science	Daily briefing: Blockbuster weight-loss drugs linked to unexpected pregnancies - 5 months ago
10	Clare Wilson New Scientist Science news source. Worldwide sciencenewstechnology	Ozempic and Wegovy linked to lower risk of alcoholism - 5 months ago

Journalists covering metformin